Dr. Alain Munoz, M.D., Ph.D. serves as the Managing Director in Cardiology and Anesthesiology at the Hôpitaux de Montpellier. Dr. Munoz serves as the Chief Executive Officer and Founder at Amistad Pharma S.A.S. and Science & Business Development SARL. He serves as a Consultant of Auris Medical AG. He is also a Venture Partner at Kurma Partners. He served as a Senior Advisor at Kurma Partners. Dr. Munoz also served as an Advisor at 123 Venture. He was a Venture Partner at IDInvest Partners SA. In 1990, he joined Fournier, as Vice President of R&D and Business Development, subsequently becoming the Senior Vice President of the Pharmaceutical Division. He served as General Partner of CDC Entreprises Capital Investissement. Dr. Munoz started his career in industry in 1980 with the Sanofi Group as Vice President of R&D. He acts as an entrepreneur developing his own projects and is a board member of several biotechnology companies. He has been Chairman of the Board of Hybrigenics Société Anonyme since July 2015. Dr. Munoz has been Co-Chair of the Clinical & Scientific Advisory Board of Zealand Pharma A/S since November 2011. He serves as a Vice President of Supervisory Board at Medesis Pharma SA. Dr. Munoz has been a Member of Supervisory Board at Novagali Pharma S.A. since September 30, 2003 and Valneva SE(Vivalis) since December 12, 2002. He serves as a Director of France Biotech and Umecrine Mood AB. He has been an Independent Director of Hybrigenics Société Anonyme since 2011 and Zealand Pharma A/S since June 2007. He served as the Chairman of Directors at Novagali Pharma S.A. He served as a Member of the Supervisory Board at Genticel S.A. since October 26, 2009 until December 2, 2015. He served as a Non-Independent Director at Zealand Pharma A/S sine 2005 until 2006. He served as a Director at Auris Medical Holding AG since December 1, 2007. He served as a Director of ERYtech Pharma SA since October 30, 2009 until January 2014. He served as a Director of TheraDiag SA. Dr. Munoz is cardiologist and anesthesiologist by training. He holds an MD degree.

 cardiology, anesthesiology, biotechnology, pharmacology